336 related articles for article (PubMed ID: 24026625)
1. Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful?
Tarazona-Santabalbina FJ; Aguilella-Fernández L
Aging Clin Exp Res; 2013 Oct; 25(5):605-9. PubMed ID: 24026625
[TBL] [Abstract][Full Text] [Related]
2. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH
Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250
[TBL] [Abstract][Full Text] [Related]
3. Pelvic fractures associated with long-term bisphosphonate therapy - case report.
Patel V; Graves L; Lukert B
J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):251-4. PubMed ID: 23728112
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment.
Yeh WL; Su CY; Chang CW; Chen CH; Fu TS; Chen LH; Lin TY
BMC Musculoskelet Disord; 2017 Dec; 18(1):527. PubMed ID: 29237448
[TBL] [Abstract][Full Text] [Related]
6. Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy.
Gomberg SJ; Wustrack RL; Napoli N; Arnaud CD; Black DM
J Clin Endocrinol Metab; 2011 Jun; 96(6):1627-32. PubMed ID: 21430030
[TBL] [Abstract][Full Text] [Related]
7. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
Cross MB; Nam D; van der Meulen MC; Bostrom MP
J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
[TBL] [Abstract][Full Text] [Related]
8. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy.
Chiang CY; Zebaze RM; Ghasem-Zadeh A; Iuliano-Burns S; Hardidge A; Seeman E
Bone; 2013 Jan; 52(1):360-5. PubMed ID: 23072919
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.
Miller PD; McCarthy EF
Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241
[TBL] [Abstract][Full Text] [Related]
10. Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide.
Carvalho NN; Voss LA; Almeida MO; Salgado CL; Bandeira F
J Clin Endocrinol Metab; 2011 Sep; 96(9):2675-80. PubMed ID: 21752890
[TBL] [Abstract][Full Text] [Related]
11. Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
Greenspan SL; Vujevich K; Britton C; Herradura A; Gruen G; Tarkin I; Siska P; Hamlin B; Perera S
Osteoporos Int; 2018 Feb; 29(2):501-506. PubMed ID: 29085957
[TBL] [Abstract][Full Text] [Related]
12. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.
Righetti M; Wach J; Desmarchelier R; Coury F
Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529
[TBL] [Abstract][Full Text] [Related]
13. [Femur fractures caused by long-term bisphosphonate therapy].
Somford MP; Thomassen BJ; Draijer WF
Ned Tijdschr Geneeskd; 2010; 154():A1218. PubMed ID: 20619008
[TBL] [Abstract][Full Text] [Related]
14. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
[TBL] [Abstract][Full Text] [Related]
15. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
[TBL] [Abstract][Full Text] [Related]
16. Atraumatic bilateral femur fracture in long-term bisphosphonate use.
Goddard MS; Reid KR; Johnston JC; Khanuja HS
Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708622
[TBL] [Abstract][Full Text] [Related]
17. Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.
Bissonnette L; April PM; Dumais R; Boire G; Roux S
Bone; 2013 Oct; 56(2):406-9. PubMed ID: 23871749
[TBL] [Abstract][Full Text] [Related]
18. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.
Chang ST; Tenforde AS; Grimsrud CD; O'Ryan FS; Gonzalez JR; Baer DM; Chandra M; Lo JC
Bone; 2012 Sep; 51(3):524-7. PubMed ID: 22634175
[TBL] [Abstract][Full Text] [Related]
19. Management of atypical femoral fracture in a patient with osteogenesis imperfecta.
Tan JY; Seow CJ
BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29269360
[TBL] [Abstract][Full Text] [Related]
20. Bilateral atypical ulnar fractures occurring after long-term treatment with bisphosphonate for 7 years and with teriparatide for 2 years: a case report.
Asano Y; Tajiri K; Yagishita S; Nakanishi H; Ishii T
Osteoporos Int; 2020 Dec; 31(12):2473-2476. PubMed ID: 32910217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
